Twist Bioscience Corporation
TWST
$47.66
-$1.98-3.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.74% | 3.07% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.74% | 3.07% | |||
| Cost of Revenue | 3.23% | 7.62% | |||
| Gross Profit | 6.17% | -0.90% | |||
| SG&A Expenses | 9.39% | 0.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.94% | 2.19% | |||
| Operating Income | -9.91% | 0.62% | |||
| Income Before Tax | -12.55% | -230.61% | |||
| Income Tax Expenses | -1.56% | 34.55% | |||
| Earnings from Continuing Operations | -12.41% | -233.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.41% | -233.09% | |||
| EBIT | -9.91% | 0.62% | |||
| EBITDA | -0.66% | -11.54% | |||
| EPS Basic | -11.22% | -232.13% | |||
| Normalized Basic EPS | -11.37% | 5.60% | |||
| EPS Diluted | -11.22% | -236.09% | |||
| Normalized Diluted EPS | -11.37% | 3.74% | |||
| Average Basic Shares Outstanding | 1.09% | 0.72% | |||
| Average Diluted Shares Outstanding | 1.09% | -1.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||